Shelby Compton's practice is focused on M&A, corporate governance, and general corporate and securities matters. She advises public and private companies on domestic and cross-border mergers, acquisitions, and divestitures of all sizes.
Shelby represents clients from a broad range of industries, including biopharmaceuticals, medical devices, pharmaceuticals, technology, energy, telecommunications, and retail. Representative clients include Abbott Laboratories, Astellas Pharma US, the Internet Corporation for Assigned Names and Numbers (ICANN), Sumitomo Corporation, and Western Digital.
Experience
- University of Notre Dame (J.D. magna cum laude 2018; Symposium Editor, The Notre Dame Law Review); Northern Arizona University (B.S. in Hospitality summa cum laude 2015)
- California
We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.
Before sending, please note:
Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.